Regulatory Services in Sri Lanka
Sri Lanka's pharmaceutical market likely to expand over the coming years. The country's growing and ageing population will act as key drivers of market growth.
Additionally, there is a latent and growing demand for the treatment of chronic diseases, which will be supported by government efforts to upgrade healthcare services. The government's pro-generic medicines policies, as well as low per-capita spending on medicines, will be an added advantage to generic producers.
Pharmaceutical expenditure during 2017 is estimated at $ 642 million with a growth of 5%. This was expected to touch $1.3 billion in 2020.